YC-1
CAS: 170632-47-0
Ref. 3D-VGA63247
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Informação sobre produto
- 1-Benzyl-3-(5-hydroxymethyl-furan-2-yl)indazole
- 1-Benzyl-3-(5-hydroxymethylfur-2-yl)indazole
- 2-Furanmethanol, 5-[1-(phenylmethyl)-1H-indazol-3-yl]-
- 5-[1-(Phenylmethyl)-1H-Indazol-3-Yl]-2-Furanmethanol
- Lificiguat
- YC 1 (pharmaceutical)
- Yc-1 (3-(5'-Hydroxymethyl-2'-Furyl)-1-Be Nzyl Indazole) \ Guanylyl Cyclase Acti
- [5-(1-Benzyl-1H-indazol-3-yl)-furan-2-yl]-methanol
- [5-(1-Benzylindazol-3-yl)furan-2-yl]methanol
YC-1 is a small molecule that inhibits the activity of cyclase, an enzyme that catalyzes the conversion of ATP to cAMP. YC-1 has been shown to induce apoptosis in cancer cells by upregulating HIF-1α and decreasing intracellular Ca2+. It also inhibits the proliferation of hl-60 cells and causes significant cytotoxicity. This drug is a potential anticancer agent due to its ability to inhibit the growth of tumor cells. YC-1 can be used for treatment of oxidative injury, such as balloon injury, since it inhibits oxidative stress-induced apoptosis. It may also be effective as a treatment for α1 subunit signal pathways, which have been implicated in diseases such as Alzheimer's disease and Parkinson's disease.
Propriedades químicas
Consulta técnica sobre: 3D-VGA63247 YC-1
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
